Madurella infection in an immunocompromised host.
Satta
R
R
Departments of Dermatology and Biomedical Science, University of Sassari, Sassari, Italy.
Sanna
S
S
Cottoni
F
F
D000368:Aged; D000935:Antifungal Agents / Q000627:therapeutic use; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D003561:Cytarabine / Q000627:therapeutic use*; D006801:Humans; D016867:Immunocompromised Host; D017964:Itraconazole / Q000627:therapeutic use; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D020461:Madurella / Q000302:isolation & purification*; D008297:Male; D008271:Mycetoma / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*
D000935:Antifungal Agents; D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine; D017964:Itraconazole